BindingDB logo
myBDB logout

BDBM332512 4-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-5-(methylamino)-1H-pyrrolo[2,3-c]pyridin-3-yl)-3-fluorobenzoic acid::US10196354, Example 30B::US9745265, 30B

SMILES: CNc1cc2c(cn(C(=O)c3c(Cl)cccc3C(F)(F)F)c2cn1)-c1ccc(cc1F)C(O)=O

InChI Key: InChIKey=LDWYFJQKADHORK-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 332512   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-gamma


(Mus musculus)
BDBM332512
PNG
(4-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-5-(meth...)
Show SMILES CNc1cc2c(cn(C(=O)c3c(Cl)cccc3C(F)(F)F)c2cn1)-c1ccc(cc1F)C(O)=O
Show InChI InChI=1S/C23H14ClF4N3O3/c1-29-19-8-13-14(12-6-5-11(22(33)34)7-17(12)25)10-31(18(13)9-30-19)21(32)20-15(23(26,27)28)3-2-4-16(20)24/h2-10H,1H3,(H,29,30)(H,33,34)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 209n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...


US Patent US9745265 (2017)


Article DOI: 10.1021/jm060742o
More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma


(Homo sapiens (Human))
BDBM332512
PNG
(4-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-5-(meth...)
Show SMILES CNc1cc2c(cn(C(=O)c3c(Cl)cccc3C(F)(F)F)c2cn1)-c1ccc(cc1F)C(O)=O
Show InChI InChI=1S/C23H14ClF4N3O3/c1-29-19-8-13-14(12-6-5-11(22(33)34)7-17(12)25)10-31(18(13)9-30-19)21(32)20-15(23(26,27)28)3-2-4-16(20)24/h2-10H,1H3,(H,29,30)(H,33,34)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
Article
US Patent
n/an/a 209n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...


US Patent US10196354 (2019)


Article DOI: 10.1021/jm0495982
More data for this
Ligand-Target Pair